ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992